Massachusetts General Hospital: Head and Neck Neoplasms trials

The registry lists 12 Head and Neck Neoplasms studies with Massachusetts General Hospital as lead sponsor. 2 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PDT For Induction Therapy For Head And Neck CancerRecruitingNCT07214987Phase 2
• Adapting the Tumor Board Model for Mental Illness and CancerRecruitingNCT05837598Not applicable
• Bridge: Proactive Psychiatry Consultation and Case Management for Patients With CancerCompletedNCT03360695Not applicableResults posted
• Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer PatientsCompletedNCT03019003Phase 1Results posted
• Supportive Oncology Care At Home RCTActive, not recruitingNCT04544046Not applicable
• AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell CarcinomaWithdrawnNCT04058145Phase 2
• Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessCompletedNCT02594696Not applicable
• 2 Phase Use Of Educational Materials In Head And Neck Cancer CenterCompletedNCT02204631Not applicable
• Ensuring Communication in Hospice by Oncology Study (ECHO)CompletedNCT02069769Not applicable
• In-Room PET in Proton Radiation TherapyCompletedNCT01228448Not applicable
• Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckCompletedNCT00513383Phase 1
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00003193Phase 1/2